These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 7557616
1. Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. Schlenger K, Höckel M, Mitze M, Schäffer U, Weikel W, Knapstein PG, Lambert A. Gynecol Oncol; 1995 Oct; 59(1):57-66. PubMed ID: 7557616 [Abstract] [Full Text] [Related]
2. Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. Höckel S, Schlenger K, Vaupel P, Höckel M. Int J Oncol; 2001 Oct; 19(4):827-32. PubMed ID: 11562762 [Abstract] [Full Text] [Related]
3. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R. Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955 [Abstract] [Full Text] [Related]
4. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Cancer Res; 1996 Oct 01; 56(19):4509-15. PubMed ID: 8813149 [Abstract] [Full Text] [Related]
5. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB. Gynecol Oncol; 2000 Apr 01; 77(1):164-70. PubMed ID: 10739706 [Abstract] [Full Text] [Related]
6. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG. J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643 [Abstract] [Full Text] [Related]
7. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Obermair A, Wanner C, Bilgi S, Speiser P, Reisenberger K, Kaider A, Kainz C, Leodolter S, Breitenecker G, Gitsch G. Cancer; 1998 Feb 15; 82(4):689-96. PubMed ID: 9477101 [Abstract] [Full Text] [Related]
8. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, Homesley HD, Zaino RJ. Gynecol Oncol; 1996 Dec 15; 63(3):304-11. PubMed ID: 8946863 [Abstract] [Full Text] [Related]
9. Expression of thymidine phosphorylase in human cervical cancer. Hata K, Takebayashi Y, Iida K, Fujiwaki R, Fukumoto M, Miyazaki K. Anticancer Res; 1999 Dec 15; 19(1B):709-16. PubMed ID: 10216481 [Abstract] [Full Text] [Related]
10. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K. Gynecol Oncol; 2000 Nov 15; 79(2):289-93. PubMed ID: 11063659 [Abstract] [Full Text] [Related]
11. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542 [Abstract] [Full Text] [Related]
12. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT. Gynecol Oncol; 2007 Dec 01; 107(3):458-63. PubMed ID: 17854872 [Abstract] [Full Text] [Related]
14. Different angiogenic pathways in human cervical cancers. Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, Yoshinouchi M, Okuda H, Kudo T. Gynecol Oncol; 1998 Jan 01; 68(1):38-44. PubMed ID: 9454658 [Abstract] [Full Text] [Related]
16. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Chen RJ, Lin YH, Chen CA, Huang SC, Chow SN, Hsieh CY. Gynecol Oncol; 1999 May 01; 73(2):184-90. PubMed ID: 10329032 [Abstract] [Full Text] [Related]
17. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA. Cancer; 2003 May 01; 97(9):2196-202. PubMed ID: 12712471 [Abstract] [Full Text] [Related]
18. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA. Laryngoscope; 2001 Jun 01; 111(6):1079-87. PubMed ID: 11404625 [Abstract] [Full Text] [Related]
19. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Sakuragi N, Takeda N, Hareyama H, Fujimoto T, Todo Y, Okamoto K, Takeda M, Wada Si, Yamamoto R, Fujimoto S. Cancer; 2000 Jun 01; 88(11):2578-83. PubMed ID: 10861436 [Abstract] [Full Text] [Related]
20. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P. Gynecol Oncol; 2001 May 01; 81(2):133-7. PubMed ID: 11330939 [Abstract] [Full Text] [Related] Page: [Next] [New Search]